BARDA Backs OraSure’s Immunoassay Diagnostic for Ebola


GLOBAL BIODEFENSE – The U.S. Department of Health and Human Services (HHS) has announced backing of a rapid antigen Ebola test with an award to OraSure Technologies, Inc. worth up to $10,364,225. The award was made via a Broad Agency Announcement for “Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures for BARDA”. Continue reading.